Unraveling the Influence of Financial Distress and Fixed Asset Intensity on Tax Avoidance : Review of evidence in the literature
Greenation International Journal of Economics and Accounting · 29.12.2025 · 3 (4) · 681-689
DOI: 10.38035/gijea.v3i4.683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Greenation International Journal of Economics and Accounting, online erschienen am 29.12.2025. Verfasst von Suci Ramadhani und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study investigates the impact of new technology adoption on production costs and the supply curve in the manufacturing industry. Using a quantitative approach, panel data from 50 manufacturing companies were collected over a 5-year period (2020-2024). The main variables analyzed were technological investment (proxy: expenditure on R&D and automation machinery), production cost per unit, and supply volume. The findings indicate that investment in new technology significantly lowers production costs per unit (p
Zitieren
APA
Ramadhani, S., Rahayu, S., & Putra, W. E. (2025). Unraveling the Influence of Financial Distress and Fixed Asset Intensity on Tax Avoidance : Review of evidence in the literature. Greenation International Journal of Economics and Accounting, 3(4), 681-689. https://doi.org/10.38035/gijea.v3i4.683
Vancouver
Ramadhani S, Rahayu S, Putra WE. Unraveling the Influence of Financial Distress and Fixed Asset Intensity on Tax Avoidance : Review of evidence in the literature. Greenation International Journal of Economics and Accounting. 2025;3(4):681-689. doi:10.38035/gijea.v3i4.683
BibTeX
@article{Ramadhani2025,
author = {Ramadhani, Suci and Rahayu, Sri and Putra, Wirmie Eka},
title = {Unraveling the Influence of Financial Distress and Fixed Asset Intensity on Tax Avoidance : Review of evidence in the literature},
journal = {Greenation International Journal of Economics and Accounting},
year = {2025},
volume = {3},
number = {4},
pages = {681--689},
doi = {10.38035/gijea.v3i4.683}
}
EUVIMED